Clinical profile of chronic liver disease with reference to hepatocellular carcinoma in RIMS

JMS - Journal of Medical Society

Volumn 25, Issue 3, 2011, Pages 15-19

  Biplap, N ^a   Bhimo, Th ^a   Suraj, Th ^a   Brojendro, Th ^a   Lalbiakdiki, ^a  

^a REGIONAL INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chronic liver disease; Hepatocellular carcinoma (HCC)

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ALCOHOLISM; ARTICLE; ASPIRATION CYTOLOGY; CHRONIC LIVER DISEASE; CONCURRENT SEXUAL PARTNERSHIP; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE GUIDED BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; RISK FACTOR; SMOKING;

EID: 84883473278     PISSN: 09724958     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Yu MH, Chang HC, Liaw YF, Lin SM, Lee SD, Liu CJ. Familial Risk of Hepatocellular Carcinoma among Chronic Hepatitis B Carriers and Their Relatives. J natl cancer Inst 2000 Jul 19; 92(14):1159.
2. th ed. London: Blackwell Science; 2002. p. 657-76.
3. th ed. New York: McGraw Hill; 2008. p. 581-82.
4. WHO media centre. Fact sheet No 164. WHO Hepatitis C [online]. Revised 2000 Oct [cited 2008]. Available f rom: URL:http://www.WHO.int/WHO Hepatitis C.html.
5. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Chronic hepatitis B from a Global perspective: Epidemiology and costs of illness. J clin Gastroenterol 2004 Nov/Dec; 38(10) supplement 3:158-68.
6. Knott SB. WHO media centre. Global HIV prevalence has leveled off [Online]. 2007 [cited 2008 Apr]. Available f rom: URL:http://www.unaids.org/.
7. Khan TS, Rizvi FJ: Hepatitis B seropositivity among chronic liver disease patients in Hazara division Pakistan. J Ayub Med Coll Abbottabad 2003, 15:54-55.
8. Khan T, Rizvi F, Rashid A. Hepatitis C seroposivity among chronic liver disease patients in hazera, Pakistan. J Ayub Med Coll Abbottabad 2003; 15 (2): 53-5.
9. Malik SH, Suliman MI. Chronic liver disease: precipitating factors for encephalopathy. The professional 2004 Oct-Dec; 2(4):446-50.
10. Johnson PJ, Krasner N, Portmann B, Eddleston ALWF, Williams R. Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis. Gut 1978 Jun; 19:1022-26.
11. Bell BP, Manos MM, Zaman A, Terrault N, Thomas A, Navarro VJ et al. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol. 2008 Nov;103(11):2727-36.
12. Garcia LLJ, Toro DH, Mayol H, Souss MJ, Dueno MI, Perez RP. Hepatocellular carcinoma: ten years experience among veterans in Puerti Rico. P R Health Sci J 2007 Jun; 26(2):103-07.
13. Michielson PP, Francque SM and Dongen JLV. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncology 2005; 3:27
14. Laraba A, Wadzali G, Sunday B, Abdulfatai O, Fatai S. Hepatitis C Virus ORIGINAL ARTICLE Infection In Nigerians With Chronic Liver Disease. The Internet Journal of Gastroenterology 2010; 9(1).
15. Lesi OA, Kehinde MO, Anomneze EE, Wali SS. Hepatitis C infection and risk of chronic liver disease in Lagos. Nig Q J Hosp Med 2002;12(1):1-4.
16. Shehu MY. Prevalence of hepatitis C virus antibodies among patients with chronic liver disease at the Jos University Teaching Hospital. A dissertation submitted to the West African College of Physicians in partial fulfillment of the requirements for the award of Fellowship of the college, 2002.
17. Raza SA, Clifford GM, Francesch S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer (2007) 96, 1127-34.
18. Michielsen PP, Francque SM and Dongen JLV. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncology 2005; 3:27.
19. Olubuyide IO, Aliyu B, Olaleye OA, Ola SO, Olawuyi F, Malabu UH et al. Hepatitis B and C virus and Hepatocellular carcinoma. Trans R Soc Trop Med Hyg 1997;91(1): 38-41.
20. Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Geodert JJ et al. The Gambia Liver Cancer Study: infection with hepatitis B and C and the risk of Hepatocellular carcinoma in West Africa. Hepatology 2004;39(1):211-219.
21. Kew MC. Hepatitis C virus infection in black patients with Hepatocellular carcinoma in Southern Africa. Princess Takamatsu Symp 1995;25:33-40.
22. Chen DS. Hepatitis C virus infection in chronic liver disease and Hepatocellular carcinoma in Taiwan. Princess Takamatsu Symp 1995; 25:27-32.
23. Tanaka K, Ikematsu H, Hirohata T, Kashiwagi S. Hepatitis C virus infection and risk of Hepatocelluar carcinoma among Japanese: possible role of type 1b(II) infection. J Natl Cancer Inst 1996; 88(11): 742-746.
24. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347:168.